Genezen is a CDMO that supplies retroviral, lentiviral and adeno-associated viral (AAV) vectors. The company is based in Fishers, Indiana and is led by CEO and President Steven Favaloro. Genezen recently completed qualification of a 25,000 sq ft GMP viral vector facility in Fishers. It raised $18.5M in growth equity funding to support expansion. The company intends to use the funds to expand its viral vector development and manufacturing capacity and capabilities. The financing is positioned to bolster its CDMO operations and scale viral vector production.

Total raised

$19M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2023